Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial
- Resource Type
- Article
- Source
- The Lancet Respiratory Medicine; December 2021, Vol. 9 Issue: 12 p1407-1418, 12p
- Subject
- Language
- ISSN
- 22132600; 22132619